ABVC
ABVC BioPharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ABVC fundamentals
ABVC BioPharma (ABVC) released its earnings on Nov 3, 2025: revenue was 795.95K (YoY +104.47%), beat estimates; EPS was -0.05 (YoY -150.00%), missed estimates.
Revenue / YoY
795.95K
+104.47%
EPS / YoY
-0.05
-150.00%
Report date
Nov 3, 2025
EPS
Revenue
Revenue & Expenses
ABVC has released its 2025 Q3 earnings report, with revenue of 795.95K, reflecting a YoY change of 104.47%, and net profit of -1.29M, showing a YoY change of -164.14%. The Sankey diagram below clearly presents ABVC's revenue sources and cost distribution.
Key Indicators
ABVC BioPharma (ABVC) key financial stats and ratios, covering profitability, financial health, and leverage.
ABVC BioPharma (ABVC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
ABVC BioPharma (ABVC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
ABVC BioPharma (ABVC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does ABVC BioPharma (ABVC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track ABVC BioPharma (ABVC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is ABVC BioPharma's gross profit margin?What guidance did ABVC BioPharma's management provide for the next earnings period?What does ABVC BioPharma do and what are its main business segments?What factors drove the changes in ABVC BioPharma's revenue and profit?What is the market's earnings forecast for ABVC BioPharma next quarter?What is the revenue and EPS growth rate for ABVC BioPharma year over year?What were the key takeaways from ABVC BioPharma's earnings call?What were the key takeaways from ABVC BioPharma’s earnings call?
